Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00118443 · ClinicalTrials.gov registry record · Phase 2

Evaluation of a School-Based Training Program for Suicide Prevention

A Phase 2 study of Suicide, sponsored by University of Rochester.

Completed
Registry status
Phase 2
Development phase
50,000
Enrollment target
1
Study location

NCT00118443 is a Phase 2 study of Suicide that has completed, run by University of Rochester. The registered enrollment target is 50,000 participants, above the 6,446-participant average among 92 other Suicide trials with a reported enrollment target (676% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00118443, a Phase 2 study of Suicide, has completed, sponsored by University of Rochester.

COMPLETED
Registry status
Phase 2
Development phase
50,000 participants
Enrollment target
1
Study location

Study Summary

This study will determine whether a training program designed to help school staff members identify adolescents at risk for suicide will increase the number of students who are referred to mental health services.

Conditions Studied

Interventions

  • BEHAVIORAL Question, Persuade, Refer (QPR) training

Study Locations (1)

Georgia

  • Cobb County School District - Marietta

Trial Details

FieldValue
Enrollment Target 50,000 participants
Start Date 2004-03
Est. Completion 2006-12
Phase Phase 2

Sponsor

University of Rochester

636 total trials

What the Registry Record Tells You About NCT00118443

The ClinicalTrials.gov registry entry for NCT00118443 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 50,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 6,446-participant average among 92 other Suicide trials with a reported enrollment target (676% higher). The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Suicide appearing as the primary indexed condition, and to 1 intervention - of which Question, Persuade, Refer (QPR) training is the first listed.

NCT00118443 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT00118443 about?

NCT00118443 is a clinical study titled "Evaluation of a School-Based Training Program for Suicide Prevention". This study will determine whether a training program designed to help school staff members identify adolescents at risk for suicide will increase the number of students who are referred to mental health services.

What is the current status of trial NCT00118443?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 50,000 participants. The study started on 2004-03. Estimated completion is 2006-12.

What conditions does trial NCT00118443 study?

This clinical trial studies the following conditions: Suicide.

What interventions are being tested in trial NCT00118443?

The interventions under investigation include: Question, Persuade, Refer (QPR) training (BEHAVIORAL).

Who is sponsoring clinical trial NCT00118443?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00118443 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Suicide

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.